Establishes the "Prescription Drug Savings and Transparency Act of 2026."

Plain-English Summary: Prescription Drug Savings and Transparency Act of 2026

This Rhode Island bill would create a new set of rules focused on making prescription drug pricing more transparent and potentially more affordable for residents. While the full details of the bill's specific provisions aren't included in the description provided, bills with this title typically aim to require drug manufacturers, pharmacy benefit managers (the middlemen who negotiate drug prices), and insurers to disclose more information about how drug prices are set and where money flows within the prescription drug supply chain.

The bill would likely affect a wide range of Rhode Islanders, including patients who pay for prescription medications, employers and insurers who provide drug coverage, and businesses in the pharmaceutical supply chain such as drug companies and pharmacy benefit managers. Depending on its specific provisions, it could impact what people pay at the pharmacy counter or how much employers pay to provide prescription drug coverage to their workers.

At this stage, the bill is still in its early phases. It was introduced in the Rhode Island Senate and referred to the Senate Health and Human Services Committee, which has recommended holding it for further study. This means the committee has not yet moved it forward for a full vote, and it may undergo changes or additional review before any further action is taken.

*Note: Because only limited bill description information was provided, this summary is based on the bill's title and general legislative context. Readers are encouraged to review the full bill text for complete details.*